Natco Pharma wins compulsory licence from Bayer; stk up

Natco will pay 6% royalty on sales to Bayer on Sorafenib.

Natco Pharma has touched a 52-week high of Rs 328.90. At 14:47 hrs the share was quoting at Rs 318.10, up Rs 21.45, or 7.23%.
 
It was trading with volumes of 173,030 shares, compared to its 5-day average of 10,520 shares, an increase of 1,544.74%.
 
In the previous trading session, the share closed up 4.88% or Rs 13.80 at Rs 296.65.

The company's trailing 12-month (TTM) EPS was at Rs 18.52 per share. (Dec, 2011). The stock's price-to-earnings (P/E) ratio was 17.22. The latest book value of the company is Rs 112.34 per share. At current value, the price-to-book value of the company was 2.84. The dividend yield of the company was 0.63%.